Navigation Links
Radyalis Announces Next Generation Of Monte Carlo Proton Therapy Planning For Advanced Radiation Cancer Treatment
Date:7/18/2014

AUSTIN, Texas, July 18, 2014 /PRNewswire-iReach/ -- Radyalis, a leader in advanced particle therapy software, will be showcasing its high performance Monte Carlo dose calculation product for proton applications simultaneously with the 2014 American Association of Physics in Medicine (AAPM) annual meeting in Austin, TX.

Radyalis breakthroughs in large-scale optimization and high-performance computing, enables for the first time clinicians to utilize the high accuracy benefits of Monte Carlo at unprecedented speeds for proton therapy dose modeling. The Radyalis Monte Carlo engine fundamentally changes today's radiotherapy workflow as the most complex patient treatment plans can be evaluated for efficacy and biological safety with high confidence in a matter of minutes.

Radyalis technology combines new algorithmic and software architecture advances for very high parallel efficiency on customer's existing hardware including single and multiple node installations, clusters, and cloud platforms, for both Linux and Windows environments.  Radyalis software is highly portable and very flexible, and designed to be integrated via a customer API or into a treatment planner.

Without compromise, Radyalis Monte Carlo supports a robust set of features. All relevant physics are accurately modeled. Simulation of complex geometries, NIST materials, and multiple beams are fully supported. Radyalis provides sophisticated dosage statistics including particle distributions, variability, fluence, and linear energy transfer, further guiding the radiation physicist.

The Radyalis fast and accurate Monte Carlo dose calculator is a key enabler for next-generation treatment plan optimization, robust planning, quality assurance, and ultimately real-time adaptive planning.  The speed and accuracy of Radyalis' Monte Carlo product provides significant ROI advantages for equipment manufacturers, treatment centers, and research organizations.

ABOUT RADYALIS

Radyalis develops and markets high performance software for radiotherapy applications that enable next-generation treatment planning and patient workflow. Based in Austin, Texas, the Radyalis team collectively brings 60+ years of related research and development experience to the particle therapy arena with focus on ultra-fast and accurate scanning-beam proton applications with extensions to other particle therapy methods. Radyalis has deep collaborations with premier oncology research hospitals and is committed to fundamentally impacting the accuracy, productivity, and cost of treatment planning through the increased use of automation.

RELATED LINKS:

http://radyalis.com

Media Contact: David LaPotin, Radyalis, 512-333-1619, david.lapotin@radyalis.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Radyalis
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Richmond Private Equity Group announces joint venture with Taking You Forward Inc.
2. Depomed Announces District Court Order in ANDA Litigation
3. Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis
4. JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes
5. Fragile Kids Foundation Announces $125,000 Grant from the James M. Cox Foundation
6. BioLife Solutions Announces Manufacturing Agreement With Somahlution LLC
7. Encapsula NanoSciences Announces Release of Two New Products
8. Contract Research Organization WCCT Global Announces Huge Success in Large Phase I Clinical Research Program
9. Webcast Alert: Heska Announces Second Quarter 2014 Earnings Conference Call Webcast
10. CVS Caremark Announces New Clinical Affiliations with Four Major Health Care Providers
11. Seres Health Completes Enrollment in a Clinical Study for SER-109 in Recurrent Clostridium difficile Infection and Announces Positive Preliminary Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... York , February 23, 2017 ... Holter Monitor Market are GE Healthcare, Koninklijke Philips N.V., ... about 48% in the global market in 2015. Strong ... two key factors assessed to be aiding these players ... Research states that the players in the global market ...
(Date:2/23/2017)... February 23, 2017 Tillotts Pharma ... Berlin office was opened in ... . The portfolio includes Entocort ® for the ... treatment of ulcerative colitis, and VistaPrep ® for ... Swiss specialty pharmaceutical company focused on the treatment of ...
(Date:2/23/2017)... and VANCOUVER, British Columbia , Feb. ... OGXI ) today announced its year end 2016 financial ... In January 2017, OncoGenex, and Achieve Life Science, Inc., a ... entered into a definitive merger agreement under which OncoGenex ... of the proposed merger, Achieve,s stockholders are expected to ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that the Blüm Study, ... children aged 3-8 with Autism, is now enrolling at three new sites. These new ... United States. , “There are currently no approved drugs that address the core ...
(Date:2/23/2017)... ... February 23, 2017 , ... Carlos Gutierrez has lived ... continued to spiritually evolve, which is the purpose of everyone in this universe. As ... ” (published by Balboa Press) attempts to guide readers to expand one’s spiritual life. ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Gevir, a ... deer antler velvet, announced its products are coming soon to Amazon.com, the world’s largest ... Shelley Thomson as a means to develop an effective natural treatment for Shelley’s Multiple ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... secure messaging services to the largest network of hospitals, health information exchanges, ... National Coordinator for Health Information Technology (ONC-HIT) 2015 Edition Health IT Module Certification ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... approach, leads to fewer trips the emergency room, fewer hospital admissions, and better ... Journal of Managed Care® (AJMC®) finds. The study can be found here ...
Breaking Medicine News(10 mins):